SCHEMBL23917243

SCHEMBL23917243

Cn1nc(-c2ccc(F)cc2)c2c(N)ncnc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.69
ALDH1A1 P00352 2/20 0.69
LMNA P02545 2/20 0.69
HTT P42858 2/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
NUDT14 O95848 1/20 0.66
NUDT5 Q9UKK9 1/20 0.66
PIK3CD O00329 13/20 0.64
PIK3CA P42336 13/20 0.64
PIK3CB P42338 13/20 0.64
PIK3CG P48736 13/20 0.64
PRKDC P78527 13/20 0.64
SRC P12931 13/20 0.64
ABL1 P00519 12/20 0.64
EGFR P00533 12/20 0.64
MTOR P42345 11/20 0.64
HCK P08631 11/20 0.64
KDR P35968 11/20 0.64
EPHB4 P54760 10/20 0.64
PI4KB Q9UBF8 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30782445 0.88 NUDT14 (0.69) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL12366 0.88 NUDT14 (0.69) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL13826003 0.87 SRC (0.68) KDM4EALDH1A1LMNAHTTNUDT14
SCHEMBL13019672 0.85 SRC (0.69) SMN1; SMN2NUDT14NUDT5PIK3CDPIK3CA
SCHEMBL21079131 0.85 NUDT14 (0.66) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL16886112 0.85 PIK3CD (0.68) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL130419 0.85 PIK3CD (0.70) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL409367 0.85 PIK3CD (0.82) NUDT14NUDT5PIK3CDPIK3CAPIK3CB
SCHEMBL128512 0.85 PIK3CD (0.60) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL23917506 0.84 NUDT14 (0.64) KDM4EALDH1A1LMNAHTTNUDT14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4719385-A2 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINES AS ANTI-INFECTIOUS AGENTS University of Vermont and State Agricultural College (US) 2026-04-08 EP disclosed
WO-2024249380-A2 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINES AS ANTI-INFECTIOUS AGENTS UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) 2024-12-05 WO disclosed
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB KDM4E 1755/4885ALDH1A1 4290/4885LMNA 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.